| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALHC | Common Stock | Sale | -$1.38M | -89.9K | -4.12% | $15.36 | 2.09M | Mar 11, 2025 | See Footnote | F1, F2, F3 |
| transaction | ALHC | Common Stock | Sale | -$1.57K | -100 | 0% | $15.72 | 2.09M | Mar 11, 2025 | See Footnote | F1, F3 |
| transaction | ALHC | Common Stock | Sale | -$808K | -52.4K | -1.11% | $15.42 | 4.68M | Mar 12, 2025 | Direct | F4, F5 |
| transaction | ALHC | Common Stock | Sale | -$11.8K | -750 | -0.02% | $15.74 | 4.68M | Mar 12, 2025 | Direct | F4, F6 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Date of Rule 10b5-1 plan adoption: 03/14/2024 |
| F2 | The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.72 to $15.69. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
| F3 | Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. |
| F4 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. |
| F5 | The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.72 to $15.715. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
| F6 | The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.72 to $15.76. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |